<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM">
      <PMID Version="1">35475028</PMID>
      <DateRevised>
        <Year>2022</Year>
        <Month>04</Month>
        <Day>29</Day>
      </DateRevised>
      <Article PubModel="Electronic-eCollection">
        <Journal>
          <ISSN IssnType="Electronic">2452-199X</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <PubDate>
              <Year>2023</Year>
              <Month>Jan</Month>
            </PubDate>
          </JournalIssue>
          <Title>Bioactive materials</Title>
          <ISOAbbreviation>Bioact Mater</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Amelioration of ligamentum flavum hypertrophy using umbilical cord mesenchymal stromal cell-derived extracellular vesicles.</ArticleTitle>
        <Pagination>
          <StartPage>139</StartPage>
          <EndPage>154</EndPage>
          <MedlinePgn>139-154</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bioactmat.2022.03.042</ELocationID>
        <Abstract>
          <AbstractText>Ligamentum flavum (LF) hypertrophy (LFH) has been recognised as one of the key contributors to lumbar spinal stenosis. Currently, no effective methods are available to ameliorate this hypertrophy. In this study, human umbilical cord mesenchymal stromal cell-derived extracellular vesicles (hUCMSC-EVs) were introduced for the first time as promising vehicles for drug delivery to treat LFH. The downregulation of miR-146a-5p and miR-221-3p expressions in human LF tissues negatively correlated with increased LF thickness. The hUCMSC-EVs enriched with these two miRNAs significantly suppressed LFH <i>in vivo</i> and notably ameliorated the progression of transforming growth factor β1(TGF-β1)-induced fibrosis <i>in vitro</i> after delivering these two miRNAs to mouse LF cells. The results further demonstrated that miR-146a-5p and miR-221-3p directly bonded to the 3'-UTR regions of SMAD4 mRNA, thereby inhibiting the TGF-β/SMAD4 signalling pathway. Therefore, this translational study determined the effectiveness of a hUCMSC-EVs-based approach for the treatment of LFH and revealed the critical target of miR-146a-5p and miR-221-3p. Our findings provide new insights into promising therapeutics using a hUCMSC-EVs-based delivery system for patients with lumbar spinal stenosis.</AbstractText>
          <CopyrightInformation>© 2022 The Authors.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Ma</LastName>
            <ForeName>Cheng</ForeName>
            <Initials>C</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Qi</LastName>
            <ForeName>Xin</ForeName>
            <Initials>X</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Pathogen Biology and Immunology, Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Wei</LastName>
            <ForeName>Yi-Fan</ForeName>
            <Initials>YF</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>Zhi</ForeName>
            <Initials>Z</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, Geriatric Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210024, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Zhang</LastName>
            <ForeName>He-Long</ForeName>
            <Initials>HL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Li</LastName>
            <ForeName>He</ForeName>
            <Initials>H</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yu</LastName>
            <ForeName>Feng-Lei</ForeName>
            <Initials>FL</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pu</LastName>
            <ForeName>Ya-Nan</ForeName>
            <Initials>YN</Initials>
            <AffiliationInfo>
              <Affiliation>Outpatient &amp; Emergency Management Department, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Huang</LastName>
            <ForeName>Yong-Can</ForeName>
            <Initials>YC</Initials>
            <AffiliationInfo>
              <Affiliation>Shenzhen Engineering Laboratory of Orthopaedic Regenerative Technologies, Department of Spine Surgery, Peking University Shenzhen Hospital, Shenzhen, 518036, China.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ren</LastName>
            <ForeName>Yong-Xin</ForeName>
            <Initials>YX</Initials>
            <AffiliationInfo>
              <Affiliation>Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, 210029, China.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>04</Month>
          <Day>08</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Bioact Mater</MedlineTA>
        <NlmUniqueID>101685294</NlmUniqueID>
        <ISSNLinking>2452-199X</ISSNLinking>
      </MedlineJournalInfo>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">ECM, extracellular matrix</Keyword>
        <Keyword MajorTopicYN="N">Extracellular vesicle</Keyword>
        <Keyword MajorTopicYN="N">Fibrosis</Keyword>
        <Keyword MajorTopicYN="N">LF, Ligamentum flavum</Keyword>
        <Keyword MajorTopicYN="N">LFH, Ligamentum flavum hypertrophy</Keyword>
        <Keyword MajorTopicYN="N">LSS, Lumbar spinal stenosis</Keyword>
        <Keyword MajorTopicYN="N">Ligamentum flavum hypertrophy</Keyword>
        <Keyword MajorTopicYN="N">MRI, magnetic resonance imaging</Keyword>
        <Keyword MajorTopicYN="N">SMAD, mothers against the decapentaplegic homolog</Keyword>
        <Keyword MajorTopicYN="N">TGF-β1, transforming growth factor-β1</Keyword>
        <Keyword MajorTopicYN="N">Umbilical cord mesenchymal stromal cells</Keyword>
        <Keyword MajorTopicYN="N">hUCMSC-EVs, human umbilical cord mesenchymal stromal cell-derived extracellular vesicles</Keyword>
        <Keyword MajorTopicYN="N">miR-146a-5p</Keyword>
        <Keyword MajorTopicYN="N">miR-221-3p</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>1</Month>
          <Day>27</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>29</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>30</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>27</Day>
          <Hour>6</Hour>
          <Minute>19</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>4</Month>
          <Day>28</Day>
          <Hour>6</Hour>
          <Minute>1</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35475028</ArticleId>
        <ArticleId IdType="pmc">PMC9014323</ArticleId>
        <ArticleId IdType="doi">10.1016/j.bioactmat.2022.03.042</ArticleId>
        <ArticleId IdType="pii">S2452-199X(22)00158-X</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Kalichman L., Cole R., Kim D.H., Li L., Suri P., Guermazi A., et al.  Spinal stenosis prevalence and association with symptoms: the Framingham Study. Spine J. 2009;9(7):545–550. doi: 10.1016/j.spinee.2009.03.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.spinee.2009.03.005</ArticleId>
            <ArticleId IdType="pmc">PMC3775665</ArticleId>
            <ArticleId IdType="pubmed">19398386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang G., Peng Z., Li J., Song Z., Wang P. Diagnostic performance of the nerve root sedimentation sign in lumbar spinal stenosis: a systematic review and meta-analysis. Neuroradiology. 2019;61(10):1111–1121. doi: 10.1007/s00234-019-02248-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00234-019-02248-3</ArticleId>
            <ArticleId IdType="pubmed">31363807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lai M.K.L., Cheung P.W.H., Cheung J.P.Y. A systematic review of developmental lumbar spinal stenosis. Eur. Spine J. 2020;29(9):2173–2187. doi: 10.1007/s00586-020-06524-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00586-020-06524-2</ArticleId>
            <ArticleId IdType="pubmed">32623513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lafian A.M., Torralba K.D. Lumbar spinal stenosis in older adults. Rheum. Dis. Clin. N. Am. 2018;44(3):501–512. doi: 10.1016/j.rdc.2018.03.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.rdc.2018.03.008</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sakai Y., Ito S., Hida T., Ito K., Harada A., Watanabe K. Clinical outcome of lumbar spinal stenosis based on new classification according to hypertrophied ligamentum flavum. J. Orthop. Sci. 2017;22(1):27–33. doi: 10.1016/j.jos.2016.08.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jos.2016.08.007</ArticleId>
            <ArticleId IdType="pubmed">27580526</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun C., Zhang H., Wang X., Liu X. Ligamentum flavum fibrosis and hypertrophy: Molecular pathways, cellular mechanisms, and future directions. Faseb. J. 2020;34(8):9854–9868. doi: 10.1096/fj.202000635R.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.202000635R</ArticleId>
            <ArticleId IdType="pubmed">32608536</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiskirchen R., Weiskirchen S., Tacke F. Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications. Mol. Aspect. Med. 2019;65:2–15. doi: 10.1016/j.mam.2018.06.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mam.2018.06.003</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sziksz E., Pap D., Lippai R., Beres N.J., Fekete A., Szabo A.J., et al.  Fibrosis related inflammatory Mediators: role of the IL-10 cytokine family. Mediat. Inflamm. 2015;2015 doi: 10.1155/2015/764641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2015/764641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Landstrom M., Liu J. The 2019 FASEB science research conference on the TGF-beta superfamily: signaling in development and disease, July 28 to august 2, 2019, west Palm Beach, Florida, USA. Faseb. J. 2019;33(12):13064–13067. doi: 10.1096/fj.201902632.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1096/fj.201902632</ArticleId>
            <ArticleId IdType="pmc">PMC6908437</ArticleId>
            <ArticleId IdType="pubmed">31795031</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng X.M., Nikolic-Paterson D.J., Lan H.Y. TGF-beta: the master regulator of fibrosis. Nat. Rev. Nephrol. 2016;12(6):325–338. doi: 10.1038/nrneph.2016.48.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrneph.2016.48</ArticleId>
            <ArticleId IdType="pubmed">27108839</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hur J.W., Bae T., Ye S., Kim J.H., Lee S., Kim K., et al.  Myofibroblast in the ligamentum flavum hypertrophic activity. Eur. Spine J. 2017;26(8):2021–2030. doi: 10.1007/s00586-017-4981-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00586-017-4981-2</ArticleId>
            <ArticleId IdType="pubmed">28180980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Amudong A., Muheremu A., Abudourexiti T. Hypertrophy of the ligamentum flavum and expression of transforming growth factor beta. J. Int. Med. Res. 2017;45(6):2036–2041. doi: 10.1177/0300060517711308.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1177/0300060517711308</ArticleId>
            <ArticleId IdType="pmc">PMC5805210</ArticleId>
            <ArticleId IdType="pubmed">28635357</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu L., Xu L., Chen Y., Xu G., Guo Q., Meng D., et al.  Rolipram plays an anti-fibrotic effect in ligamentum flavum fibroblasts by inhibiting the activation of ERK1/2. BMC Muscoskel. Disord. 2021;22(1):818. doi: 10.1186/s12891-021-04712-9.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12891-021-04712-9</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xie Q., Liu R., Jiang J., Peng J., Yang C., Zhang W., et al.  What is the impact of human umbilical cord mesenchymal stem cell transplantation on clinical treatment? Stem Cell Res. Ther. 2020;11(1):519. doi: 10.1186/s13287-020-02011-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-020-02011-z</ArticleId>
            <ArticleId IdType="pmc">PMC7705855</ArticleId>
            <ArticleId IdType="pubmed">33261658</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Silini A.R., Di Pietro R., Lang-Olip I., Alviano F., Banerjee A., Basile M., et al.  Perinatal derivatives: where do we stand? A roadmap of the human Placenta and consensus for tissue and cell nomenclature. Front. Bioeng. Biotechnol. 2020;8 doi: 10.3389/fbioe.2020.610544.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fbioe.2020.610544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shang F., Yu Y., Liu S., Ming L., Zhang Y., Zhou Z., et al.  Advancing application of mesenchymal stem cell-based bone tissue regeneration. Bioact. Mater. 2021;6(3):666–683. doi: 10.1016/j.bioactmat.2020.08.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bioactmat.2020.08.014</ArticleId>
            <ArticleId IdType="pmc">PMC7509590</ArticleId>
            <ArticleId IdType="pubmed">33005830</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu J., Peng D., You J., Zhou O., Qiu H., Hao C., et al.  Type 2 alveolar epithelial cells differentiated from human umbilical cord mesenchymal stem cells alleviate mouse pulmonary fibrosis through beta-catenin-regulated cell apoptosis. Stem Cell. Dev. 2021;30(13):660–670. doi: 10.1089/scd.2020.0208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1089/scd.2020.0208</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhou Q., Gu T., Zhang Y., Li H., Zhuansun X., Xu S., et al.  Human umbilical cord mesenchymal stem cells ameliorate hepatic stellate cell activation and liver fibrosis by upregulating MicroRNA-455-3p through suppression of p21-activated Kinase-2. BioMed Res. Int. 2021;2021 doi: 10.1155/2021/6685605.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2021/6685605</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Distler J.H.W., Gyorfi A.H., Ramanujam M., Whitfield M.L., Konigshoff M., Lafyatis R. Shared and distinct mechanisms of fibrosis. Nat. Rev. Rheumatol. 2019;15(12):705–730. doi: 10.1038/s41584-019-0322-7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41584-019-0322-7</ArticleId>
            <ArticleId IdType="pubmed">31712723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun H., Pratt R.E., Hodgkinson C.P., Dzau V.J. Sequential paracrine mechanisms are necessary for the therapeutic benefits of stem cell therapy. Am. J. Physiol. Cell Physiol. 2020;319(6):C1141–C1150. doi: 10.1152/ajpcell.00516.2019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpcell.00516.2019</ArticleId>
            <ArticleId IdType="pubmed">33026832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Niel G., D'Angelo G., Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat. Rev. Mol. Cell Biol. 2018;19(4):213–228. doi: 10.1038/nrm.2017.125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm.2017.125</ArticleId>
            <ArticleId IdType="pubmed">29339798</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shah R., Patel T., Freedman J.E. Circulating extracellular vesicles in human disease. N. Engl. J. Med. 2018;379(10):958–966. doi: 10.1056/NEJMra1704286.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJMra1704286</ArticleId>
            <ArticleId IdType="pubmed">30184457</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalluri R., LeBleu V.S. The biology, function, and biomedical applications of exosomes. Science. 2020;367(6478) doi: 10.1126/science.aau6977.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/science.aau6977</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wiklander O.P.B., Brennan M.A., Lotvall J., Breakefield X.O., El Andaloussi S. Advances in therapeutic applications of extracellular vesicles. Sci. Transl. Med. 2019;11(492) doi: 10.1126/scitranslmed.aav8521.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/scitranslmed.aav8521</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang G., Zhu Y., Ali D.J., Tian T., Xu H., Si K., et al.  Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J. Nanobiotechnol. 2020;18(1):10. doi: 10.1186/s12951-019-0563-2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12951-019-0563-2</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cui Y., Guo Y., Kong L., Shi J., Liu P., Li R., et al.  A bone-targeted engineered exosome platform delivering siRNA to treat osteoporosis. Bioact. Mater. 2022;10:207–221. doi: 10.1016/j.bioactmat.2021.09.015.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bioactmat.2021.09.015</ArticleId>
            <ArticleId IdType="pmc">PMC8636739</ArticleId>
            <ArticleId IdType="pubmed">34901540</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu T., Zhang Q., Zhang J., Li C., Miao Y.R., Lei Q., et al.  EVmiRNA: a database of miRNA profiling in extracellular vesicles. Nucleic Acids Res. 2019;47(D1):D89–D93. doi: 10.1093/nar/gky985.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gky985</ArticleId>
            <ArticleId IdType="pmc">PMC6323938</ArticleId>
            <ArticleId IdType="pubmed">30335161</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun C., Tian J., Liu X., Guan G. MiR-21 promotes fibrosis and hypertrophy of ligamentum flavum in lumbar spinal canal stenosis by activating IL-6 expression. Biochem. Biophys. Res. Commun. 2017;490(3):1106–1111. doi: 10.1016/j.bbrc.2017.06.182.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2017.06.182</ArticleId>
            <ArticleId IdType="pubmed">28669725</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y.Q., Zhang Z.H., Zheng Y.F., Feng S.Q. MicroRNA-221 regulates hypertrophy of ligamentum flavum in lumbar spinal stenosis by targeting TIMP-2. Spine. 2016;41(4):275–282. doi: 10.1097/BRS.0000000000001226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/BRS.0000000000001226</ArticleId>
            <ArticleId IdType="pubmed">26571175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen J., Liu Z., Zhong G., Qian L., Li Z., Qiao Z., et al.  Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level. Dis. Markers. 2014;2014:786543. doi: 10.1155/2014/786543.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1155/2014/786543</ArticleId>
            <ArticleId IdType="pmc">PMC4052175</ArticleId>
            <ArticleId IdType="pubmed">24963214</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>George K.M., Hernandez N.S., Breton J., Cooper B., Dowd R.S., Nail J., et al.  Lumbar ligamentum flavum burden: Evaluating the role of ATTRwt amyloid deposition in ligamentum flavum thickness at all lumbar levels. Clin. Neurol. Neurosurg. 2021;206:106708. doi: 10.1016/j.clineuro.2021.106708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.clineuro.2021.106708</ArticleId>
            <ArticleId IdType="pubmed">34053807</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zheng Z., Ao X., Li P., Lian Z., Jiang T., Zhang Z., et al.  CRLF1 is a key regulator in the ligamentum flavum hypertrophy. Front. Cell Dev. Biol. 2020;8:858. doi: 10.3389/fcell.2020.00858.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcell.2020.00858</ArticleId>
            <ArticleId IdType="pmc">PMC7533558</ArticleId>
            <ArticleId IdType="pubmed">33072735</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Che H., Li J., Li Y., Ma C., Liu H., Qin J., et al.  p16 deficiency attenuates intervertebral disc degeneration by adjusting oxidative stress and nucleus pulposus cell cycle. Elife. 2020;9 doi: 10.7554/eLife.52570.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7554/eLife.52570</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li C., Samulski R.J. Engineering adeno-associated virus vectors for gene therapy. Nat. Rev. Genet. 2020;21(4):255–272. doi: 10.1038/s41576-019-0205-4.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41576-019-0205-4</ArticleId>
            <ArticleId IdType="pubmed">32042148</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Harrell C.R., Fellabaum C., Jovicic N., Djonov V., Arsenijevic N., Volarevic V. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8(5) doi: 10.3390/cells8050467.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/cells8050467</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee K.S., Lee J., Kim H.K., Yeom S.H., Woo C.H., Jung Y.J., et al.  Extracellular vesicles from adipose tissue-derived stem cells alleviate osteoporosis through osteoprotegerin and miR-21-5p. J. Extracell. Vesicles. 2021;10(12) doi: 10.1002/jev2.12152.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jev2.12152</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jeong J.O., Han J.W., Kim J.M., Cho H.J., Park C., Lee N., et al.  Malignant tumor formation after transplantation of short-term cultured bone marrow mesenchymal stem cells in experimental myocardial infarction and diabetic neuropathy. Circ. Res. 2011;108(11):1340–1347. doi: 10.1161/CIRCRESAHA.110.239848.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCRESAHA.110.239848</ArticleId>
            <ArticleId IdType="pmc">PMC3109741</ArticleId>
            <ArticleId IdType="pubmed">21493893</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Brown C., McKee C., Bakshi S., Walker K., Hakman E., Halassy S., et al.  Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med. 2019;13(9):1738–1755. doi: 10.1002/term.2914.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/term.2914</ArticleId>
            <ArticleId IdType="pubmed">31216380</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang D., Chen X., Wang J., Lou Q., Lou Y., Li L., et al.  Dysregulated lung commensal Bacteria drive interleukin-17B production to promote pulmonary fibrosis through their outer membrane vesicles. Immunity. 2019;50(3):692–706. doi: 10.1016/j.immuni.2019.02.001. e7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2019.02.001</ArticleId>
            <ArticleId IdType="pubmed">30824326</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Han C., Zhou J., Liang C., Liu B., Pan X., Zhang Y., et al.  Human umbilical cord mesenchymal stem cell derived exosomes encapsulated in functional peptide hydrogels promote cardiac repair. Biomater Sci. 2019;7(7):2920–2933. doi: 10.1039/c9bm00101h.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c9bm00101h</ArticleId>
            <ArticleId IdType="pubmed">31090763</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang Z.G., He Z.Y., Liang S., Yang Q., Cheng P., Chen A.M. Comprehensive proteomic analysis of exosomes derived from human bone marrow, adipose tissue, and umbilical cord mesenchymal stem cells. Stem Cell Res. Ther. 2020;11(1):511. doi: 10.1186/s13287-020-02032-8.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s13287-020-02032-8</ArticleId>
            <ArticleId IdType="pmc">PMC7694919</ArticleId>
            <ArticleId IdType="pubmed">33246507</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chuang H.C., Tsai K.L., Tsai K.J., Tu T.Y., Shyong Y.J., Jou I.M., et al.  Oxidative stress mediates age-related hypertrophy of ligamentum flavum by inducing inflammation, fibrosis, and apoptosis through activating Akt and MAPK pathways. Aging (Albany NY) 2020;12(23):24168–24183. doi: 10.18632/aging.104105.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/aging.104105</ArticleId>
            <ArticleId IdType="pmc">PMC7762458</ArticleId>
            <ArticleId IdType="pubmed">33223505</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mori T., Sakai Y., Kayano M., Matsuda A., Oboki K., Matsumoto K., et al.  MicroRNA transcriptome analysis on hypertrophy of ligamentum flavum in patients with lumbar spinal stenosis. Spine Surg Relat Res. 2017;1(4):211–217. doi: 10.22603/ssrr.1.2017-0023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.22603/ssrr.1.2017-0023</ArticleId>
            <ArticleId IdType="pmc">PMC6698563</ArticleId>
            <ArticleId IdType="pubmed">31440636</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wu L., Rong C., Zhou Q., Zhao X., Zhuansun X.M., Wan S., et al.  Bone marrow mesenchymal stem cells ameliorate cisplatin-induced renal fibrosis via miR-146a-5p/tfdp2 Axis in renal tubular epithelial cells. Front. Immunol. 2020;11:623693. doi: 10.3389/fimmu.2020.623693.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fimmu.2020.623693</ArticleId>
            <ArticleId IdType="pmc">PMC7921314</ArticleId>
            <ArticleId IdType="pubmed">33664736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sun Y., Li Y., Wang H., Li H., Liu S., Chen J., et al.  miR-146a-5p acts as a negative regulator of TGF-beta signaling in skeletal muscle after acute contusion. Acta Biochim. Biophys. Sin. 2017;49(7):628–634. doi: 10.1093/abbs/gmx052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/abbs/gmx052</ArticleId>
            <ArticleId IdType="pubmed">28510617</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xu Y-q, Zhang Z-h, Zheng Y-f, Feng S-q. MicroRNA-221 regulates hypertrophy of ligamentum flavum in lumbar spinal stenosis by targeting TIMP-2. Spine. 2016;41(4):275–282. doi: 10.1097/brs.0000000000001226.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/brs.0000000000001226</ArticleId>
            <ArticleId IdType="pubmed">26571175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Meng Q., Liang C., Hua J., Zhang B., Liu J., Zhang Y., et al.  A miR-146a-5p/TRAF6/NF-kB p65 axis regulates pancreatic cancer chemoresistance: functional validation and clinical significance. Theranostics. 2020;10(9):3967–3979. doi: 10.7150/thno.40566.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.40566</ArticleId>
            <ArticleId IdType="pmc">PMC7086345</ArticleId>
            <ArticleId IdType="pubmed">32226532</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li X., Liao J., Su X., Li W., Bi Z., Wang J., et al.  Human urine-derived stem cells protect against renal ischemia/reperfusion injury in a rat model via exosomal miR-146a-5p which targets IRAK1. Theranostics. 2020;10(21):9561–9578. doi: 10.7150/thno.42153.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.42153</ArticleId>
            <ArticleId IdType="pmc">PMC7449916</ArticleId>
            <ArticleId IdType="pubmed">32863945</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Qiu M., Li T., Wang B., Gong H., Huang T. miR-146a-5p regulated cell proliferation and apoptosis by targeting SMAD3 and SMAD4. Protein Pept. Lett. 2020;27(5):411–418. doi: 10.2174/0929866526666190911142926.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2174/0929866526666190911142926</ArticleId>
            <ArticleId IdType="pmc">PMC7460735</ArticleId>
            <ArticleId IdType="pubmed">31544687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu F.Y., Gan C.W., Wang M.X., Sun B.C., Li F.J., Qiu Y.H., et al.  MiR-146a-5p inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells by regulating NF-kappaB signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 2020;24(7):3717–3723. doi: 10.26355/eurrev_202004_20835.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.26355/eurrev_202004_20835</ArticleId>
            <ArticleId IdType="pubmed">32329848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Verjans R., Peters T., Beaumont F.J., van Leeuwen R., van Herwaarden T., Verhesen W., et al.  MicroRNA-221/222 family counteracts myocardial fibrosis in Pressure overload-induced heart failure. Hypertension. 2018;71(2):280–288. doi: 10.1161/HYPERTENSIONAHA.117.10094.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/HYPERTENSIONAHA.117.10094</ArticleId>
            <ArticleId IdType="pubmed">29255073</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zou Y., Cai Y., Lu D., Zhou Y., Yao Q., Zhang S. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFbeta1 and lipopolysaccharide. Cell. Signal. 2017;39:1–8. doi: 10.1016/j.cellsig.2017.07.016.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cellsig.2017.07.016</ArticleId>
            <ArticleId IdType="pubmed">28739486</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yuan B.Y., Chen Y.H., Wu Z.F., Zhuang Y., Chen G.W., Zhang L., et al.  MicroRNA-146a-5p attenuates fibrosis-related molecules in irradiated and TGF-beta1-treated human hepatic stellate cells by regulating PTPRA-SRC signaling. Radiat. Res. 2019;192(6):621–629. doi: 10.1667/RR15401.1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1667/RR15401.1</ArticleId>
            <ArticleId IdType="pubmed">31560641</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cao J.-Y., Wang B., Tang T.-T., Wen Y., Li Z.-L., Feng S.-T., et al.  Exosomal miR-125b-5p deriving from mesenchymal stem cells promotes tubular repair by suppression of p53 in ischemic acute kidney injury. Theranostics. 2021;11(11):5248–5266. doi: 10.7150/thno.54550.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7150/thno.54550</ArticleId>
            <ArticleId IdType="pmc">PMC8039965</ArticleId>
            <ArticleId IdType="pubmed">33859745</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cheng L., Hill A.F. Therapeutically harnessing extracellular vesicles. Nat. Rev. Drug Discov. 2022 doi: 10.1038/s41573-022-00410-w.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41573-022-00410-w</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villata S., Canta M., Cauda V. EVs and bioengineering: from cellular Products to engineered nanomachines. Int. J. Mol. Sci. 2020;21(17) doi: 10.3390/ijms21176048.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/ijms21176048</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang C., Wang M., Xia K., Wang J., Cheng F., Shi K., et al.  A bioactive injectable self-healing anti-inflammatory hydrogel with ultralong extracellular vesicles release synergistically enhances motor functional recovery of spinal cord injury. Bioact. Mater. 2021;6(8):2523–2534. doi: 10.1016/j.bioactmat.2021.01.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bioactmat.2021.01.029</ArticleId>
            <ArticleId IdType="pmc">PMC7873581</ArticleId>
            <ArticleId IdType="pubmed">33615043</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tao S.C., Huang J.Y., Gao Y., Li Z.X., Wei Z.Y., Dawes H., et al.  Small extracellular vesicles in combination with sleep-related circRNA3503: a targeted therapeutic agent with injectable thermosensitive hydrogel to prevent osteoarthritis. Bioact. Mater. 2021;6(12):4455–4469. doi: 10.1016/j.bioactmat.2021.04.031.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bioactmat.2021.04.031</ArticleId>
            <ArticleId IdType="pmc">PMC8120802</ArticleId>
            <ArticleId IdType="pubmed">34027234</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
